Stocks / Alpha Vantage News Sentiment

UBS Adjusts Price Target on MetLife to $105 From $102, Maintains Buy Rating

UBS has increased its price target for MetLife (MET) from $102 to $105, while reaffirming a Buy rating on the stock. This adjustment reflects an updated outlook by the financial services firm. The article also provides a summary of recent news and analyst actions concerning MetLife.